Design Considerations for Macroencapsulation Devices for Stem Cell Derived Islets for the Treatment of Type 1 Diabetes-Reference-Cited by-同舟云学术

Design Considerations for Macroencapsulation Devices for Stem Cell Derived Islets for the Treatment of Type 1 Diabetes

Published:2021-06-21 Issue:16 Volume:8 Page:2100820
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Adv. Sci.

Author:

Goswami Debkalpa¹^ORCID,Domingo‐Lopez Daniel A.²^ORCID,Ward Niamh A.³^ORCID,Millman Jeffrey R.⁴⁵^ORCID,Duffy Garry P.²⁶⁷^ORCID,Dolan Eimear B.³^ORCID,Roche Ellen T.¹⁸^ORCID

Affiliation:

1. Institute for Medical Engineering and Science Massachusetts Institute of Technology Cambridge MA 02139 USA

2. Department of Anatomy College of Medicine, Nursing, and Health Sciences National University of Ireland Galway Galway H91 TK33 Ireland

3. Department of Biomedical Engineering School of Engineering College of Science and Engineering National University of Ireland Galway Galway H91 TK33 Ireland

4. Division of Endocrinology, Metabolism & Lipid Research Washington University School of Medicine St. Louis MO 63110 USA

5. Department of Biomedical Engineering Washington University in St. Louis St. Louis MO 63110 USA

6. Advanced Materials and BioEngineering Research Centre (AMBER) Trinity College Dublin Dublin D02 PN40 Ireland

7. CÚRAM, Centre for Research in Medical Devices National University of Ireland Galway Galway H91 TK33 Ireland

8. Department of Mechanical Engineering Massachusetts Institute of Technology Cambridge MA 02139 USA

Funder

Science Foundation Ireland

H2020 Marie Skłodowska-Curie Actions

Juvenile Diabetes Research Foundation International

National Institutes of Health

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202100820

Reference196 articles.

1. Transplantation of macroencapsulated human islets within the bioartificial pancreas βAir to patients with type 1 diabetes mellitus

2. Acquisition of Dynamic Function in Human Stem Cell-Derived β Cells

3. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells

4. Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices

5. The TheraCyte™ Device Protects against Islet Allograft Rejection in Immunized Hosts

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead;Nature Reviews Endocrinology;2024-09-03

2. Recent progress in modeling and treating diabetes using stem cell-derived islets;Stem Cells Translational Medicine;2024-08-19

3. Droplet-based microfluidics: an efficient high-throughput portable system for cell encapsulation;Journal of Microencapsulation;2024-07-30

4. Identification of unique cell type responses in pancreatic islets to stress;Nature Communications;2024-07-02

5. An injectable and retrievable bioartificial pancreas fabricated by time-sequentially assembling islets-laden microgels for minimally invasive treatment of type 1 diabetes;Chemical Engineering Journal;2024-07